Twincretin drug Tirzepatide shows unmatched efficacy in weight loss and diabetes management

FHS
July 15, 2024
4:30 am

Tirzepatide, a novel twincretin drug, significantly improves weight loss and glycemic control in obese and type 2 diabetes patients, outperforming traditional treatments in clinical trials.

Schrödinger takes a step forward with AlphaFold in drug R&D, as biotech hits a pipeline ‘inflection’

Schrödinger has workshopped a fix for one of the biggest problems with AlphaFold-generated protein structure predictions, in what the company is describing as a notable

February 2, 2024

Medtronic exits ventilator business, creates new patient monitoring and respiratory unit

Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. By the numbers Q3 FY2024 revenue: $8.09

February 20, 2024

Cadaveric pituitary-derived growth hormone delivery influences iatrogenic Alzheimer’s Disease

Recipients of cadaver-derived pituitary growth hormone (c-hGH) developed biomarker changes in the realm of Alzheimer’s disease (AD).

January 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.